Gerald DeNardo

Title(s)Professor Emeritus, MED: Int Med Hematology/Oncology
SchoolSchool of Medicine
AddressBulkley Bldg/UCDMC
CA 95817
Phone916-734-3787
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer. 2013; 2013:828329. Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB. PMID: 23365757; PMCID: PMC3556872.
      View in: PubMed   Mentions: 23  
    2. Concepts, consequences, and implications of theranosis. Semin Nucl Med. 2012 May; 42(3):147-50. DeNardo GL, DeNardo SJ. PMID: 22475423.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    3. Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT). Cancer Biother Radiopharm. 2010 Oct; 25(5):507-9. Denardo GL, Macey DJ. PMID: 20849311.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm. Semin Nucl Med. 2010 Mar; 40(2):136-44. DeNardo G, DeNardo S. PMID: 20113681.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    5. Health care in the United States in 2009: both sides of the "counter". Cancer Biother Radiopharm. 2009 Oct; 24(5):515-7. DeNardo GL, DeNardo SJ. PMID: 19877880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Changes Occur But Often Little Really Changes. Cancer Biotherapy & Radiopharmaceuticals. 2009 Aug 1; 24(4):377-377. DeNardo DG. .
      View in: Publisher Site   Mentions:
    7. Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells. Mol Cancer. 2009 Apr 22; 8:25. Balhorn R, Hok S, DeNardo S, Natarajan A, Mirick G, Corzett M, Denardo G. PMID: 19383174; PMCID: PMC2680800.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    8. Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia. Int J Oncol. 2009 Feb; 34(2):511-6. DeNardo GL, Mirick GR, Hok S, DeNardo SJ, Beckett LA, Adamson GN, Balhorn RL. PMID: 19148487.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    9. Update: Turning the heat on cancer. Cancer Biother Radiopharm. 2008 Dec; 23(6):671-80. DeNardo GL, DeNardo SJ. PMID: 20443694; PMCID: PMC2987268.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    10. Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging. Cancer Biother Radiopharm. 2008 Dec; 23(6):783-96. DeNardo GL, Natarajan A, Hok S, Mirick G, DeNardo SJ, Corzett M, Sysko V, Lehmann J, Beckett L, Balhorn R. PMID: 20443696; PMCID: PMC2936943.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    11. Molecular imaging/therapy: it's only useful if it's useful--and available. J Nucl Med. 2008 Sep; 49(9):40N-42N, 44N. DeNardo G. PMID: 18765580.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies? Cancer Biother Radiopharm. 2008 Aug; 23(4):383-97. DeNardo GL, DeNardo SJ, Balhorn R. PMID: 18771343; PMCID: PMC2988689.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    13. Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy. Bioorg Med Chem Lett. 2008 Sep 01; 18(17):4802-5. Natarajan A, Kumaresan PR, Denardo SJ, Denardo GL, Mirick G, Lam KS. PMID: 18701282.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    14. Targeted radionuclide therapy. Med Phys. 2008 Jul; 35(7):3062-8. Williams LE, DeNardo GL, Meredith RF. PMID: 18697529; PMCID: PMC2673558.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    15. NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjug Chem. 2008 Jun; 19(6):1211-8. Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ. PMID: 18517234; PMCID: PMC3573696.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    16. Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice. Cancer Biol Ther. 2008 Jul; 7(7):1116-27. Dadachova E, Revskaya E, Sesay MA, Damania H, Boucher R, Sellers RS, Howell RC, Burns L, Thornton GB, Natarajan A, Mirick GR, DeNardo SJ, DeNardo GL, Casadevall A. PMID: 18535406.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    17. Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm. 2008 Apr; 23(2):265-71. Lehmann J, Natarajan A, Denardo GL, Ivkov R, Foreman AR, Catapano C, Mirick G, Quang T, Gruettner C, Denardo SJ. PMID: 18454696.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    18. Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. Cancer Biother Radiopharm. 2008 Feb; 23(1):82-91. Natarajan A, Xiong CY, Gruettner C, DeNardo GL, DeNardo SJ. PMID: 18298332.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    19. Editorial 2008 State of Affairs for Cancer Biotherapy & Radiopharmaceuticals. Cancer Biotherapy & Radiopharmaceuticals. 2008 Feb 1; 23(1):1-2. DeNardo DG, Oldham OR. .
      View in: Publisher Site   Mentions:
    20. The conundrum of personalized cancer management, drug development, and economics. Cancer Biother Radiopharm. 2007 Dec; 22(6):719-21. DeNardo GL. PMID: 18158762.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma. Int J Oncol. 2007 Oct; 31(4):729-40. DeNardo GL, Hok S, Van Natarajan A, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Yuan A, Perkins J, Sysko VV, Lehmann J, Balhorn RL. PMID: 17786303.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    22. Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5621s-5628s. Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL. PMID: 17875798.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    23. Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues. Cancer Biother Radiopharm. 2007 Aug; 22(4):556-63. Siantar CL, DeNardo GL, Lam K, Yuan A, Daly T, DeNardo SJ. PMID: 17803451.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    24. Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2007 Aug; 22(4):521-30. Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR. PMID: 17803447.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    25. Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules. Cancer Biother Radiopharm. 2007 Aug; 22(4):531-42. Albrecht H, Cosman M, Ngu-Schwemlein M, Corzett M, Curran KW, Dolan C, Fang X, DeNardo SJ, DeNardo GL, Balhorn R. PMID: 17803448.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    26. Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma. J Nucl Med. 2007 Aug; 48(8):1338-47. DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL. PMID: 17631545.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    27. Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines. Leuk Lymphoma. 2007 May; 48(5):944-56. Tobin E, Denardo G, Zhang N, Epstein AL, Liu C, Denardo S. PMID: 17487739.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    28. Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers. Q J Nucl Med Mol Imaging. 2007 Dec; 51(4):304-13. Albrecht H, Denardo GL, Denardo SJ. PMID: 17464275.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    29. Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia. Bioconjug Chem. 2007 May-Jun; 18(3):912-21. Hok S, Natarajan A, Balhorn R, DeNardo SJ, DeNardo GL, Perkins J. PMID: 17373772.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    30. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. J Nucl Med. 2007 Mar; 48(3):437-44. DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R. PMID: 17332622.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    31. On the analysis of count data of birth-and-death process type: with application to molecularly targeted cancer therapy. Stat Med. 2007 Feb 28; 26(5):1114-35. Liu H, Beckett LA, DeNardo GL. PMID: 16755532.
      View in: PubMed   Mentions: 1     Fields:    
    32. Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries. Bioconjug Chem. 2007 Jan-Feb; 18(1):175-82. Kumaresan PR, Natarajan A, Song A, Wang X, Liu R, DeNardo G, DeNardo S, Lam KS. PMID: 17226971.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    33. Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells. Cancer Biother Radiopharm. 2006 Dec; 21(6):645-54. West J, Perkins J, Hok S, Balhorn R, Lightstone FC, Cosman M, DeNardo SJ, DeNardo GL. PMID: 17257080.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    34. Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition. Chem Commun (Camb). 2007 Feb 21; (7):695-7. Natarajan A, Du W, Xiong CY, DeNardo GL, DeNardo SJ, Gervay-Hague J. PMID: 17392953.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    35. Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1192-8. Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ. PMID: 16965873.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int J Oncol. 2006 Jul; 29(1):49-55. Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ. PMID: 16773184.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    37. Development of tumor targeting anti-MUC-1 multimer: effects of di-scFv unpaired cysteine location on PEGylation and tumor binding. Protein Eng Des Sel. 2006 Aug; 19(8):359-67. Xiong CY, Natarajan A, Shi XB, Denardo GL, Denardo SJ. PMID: 16760193.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    38. Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapy. Cancer Biother Radiopharm. 2006 Apr; 21(2):85-7. Denardo GL. PMID: 16706628.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    39. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunol Immunother. 2006 Dec; 55(12):1451-8. Azinovic I, DeNardo GL, Lamborn KR, Mirick G, Goldstein D, Bradt BM, DeNardo SJ. PMID: 16496145; PMCID: PMC11030743.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCTClinical Trials
    40. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility. J Immunol Methods. 2006 Mar 20; 310(1-2):100-16. Albrecht H, Denardo GL, Denardo SJ. PMID: 16499921.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    41. Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S89-95. DeNardo SJ, Denardo GL. PMID: 16979448.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    42. Cure of incurable lymphoma. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S46-56. DeNardo GL, Sysko VV, DeNardo SJ. PMID: 16979440.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft. Cancer Biother Radiopharm. 2005 Dec; 20(6):614-9. Miers L, DeNardo SJ, Lamborn K, DeNardo GL. PMID: 16398613.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    44. Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody. Cancer Biother Radiopharm. 2005 Dec; 20(6):662-70. Shen S, DeNardo GL, Yuan A, Hartmann-Siantar C, O'Donnell RT, DeNardo SJ. PMID: 16398618.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7187s-7194s. DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL. PMID: 16203820.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    46. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7093s-7103s. Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, DeNardo GL. PMID: 16203808.
      View in: PubMed   Mentions: 69     Fields:    Translation:Animals
    47. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7158s-7163s. Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. PMID: 16203816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    48. Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7087s-7092s. DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R. PMID: 16203807.
      View in: PubMed   Mentions: 65     Fields:    Translation:Animals
    49. Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7075s-7079s. DeNardo GL, Tobin E, Chan K, Bradt BM, DeNardo SJ. PMID: 16203805.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    50. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. PMID: 16115934.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCTClinical Trials
    51. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs). Semin Nucl Med. 2005 Jul; 35(3):202-11. DeNardo GL. PMID: 16098294.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    52. Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. J Nucl Med. 2005 Jun; 46(6):1034-41. Shen S, DeNardo SJ, Richman CM, Yuan A, Siantar CH, O'Donnell RT, Kroger LA, DeNardo GL. PMID: 15937317.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    53. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system. Phys Med Biol. 2005 Mar 07; 50(5):947-58. Lehmann J, Hartmann Siantar C, Wessol DE, Wemple CA, Nigg D, Cogliati J, Daly T, Descalle MA, Flickinger T, Pletcher D, Denardo G. PMID: 15798267.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S27-35. DeNardo GL. PMID: 15786023.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals. Bioconjug Chem. 2005 Jan-Feb; 16(1):113-21. Natarajan A, Xiong CY, Albrecht H, DeNardo GL, DeNardo SJ. PMID: 15656582.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    56. MINERVA: a multi-modality plugin-based radiation therapy treatment planning system. Radiat Prot Dosimetry. 2005; 116(1-4 Pt 2):202-7. Wemple CA, Wessol DE, Nigg DW, Cogliati JJ, Milvich M, Fredrickson CM, Perkins M, Harkin GJ, Hartmann-Siantar CL, Lehmann J, Flickinger T, Pletcher D, Yuan A, DeNardo GL. PMID: 16604627.
      View in: PubMed   Mentions: 1     Fields:    Translation:PHPublic Health
    57. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Q J Nucl Med Mol Imaging. 2004 Dec; 48(4):251-7. Mirick GR, Bradt BM, Denardo SJ, Denardo GL. PMID: 15640788.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    58. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. J Nucl Med. 2004 Oct; 45(10):1725-33. Wessels BW, Bolch WE, Bouchet LG, Breitz HB, Denardo GL, Meredith RF, Stabin MG, Sgouros G, American Association of Physicists in Medicine. PMID: 15471841.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    59. New directions in radioimmunotherapy of non-Hodgkin's lymphoma. Clin Lymphoma. 2004 Oct; 5 Suppl 1:S4. DeNardo GL. PMID: 15498148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Radiometals as payloads for radioimmunotherapy for lymphoma. Clin Lymphoma. 2004 Oct; 5 Suppl 1:S5-10. DeNardo GL, Kennel SJ, Siegel JA, Denardo SJ. PMID: 15498149.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    61. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells. Cancer Biother Radiopharm. 2004 Oct; 19(5):545-61. Liu C, DeNardo G, Tobin E, DeNardo S. PMID: 15650447.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    62. Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients. Cancer Biother Radiopharm. 2004 Feb; 19(1):85-92. DeNardo GL, DeNardo SJ. PMID: 15068616.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    63. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Bioconjug Chem. 2004 Jan-Feb; 15(1):16-26. Albrecht H, Burke PA, Natarajan A, Xiong CY, Kalicinsky M, DeNardo GL, DeNardo SJ. PMID: 14733579.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    64. Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2003 Oct; 18(5):673-4. Juweid M, DeNardo GL, Graham M, Vose J. PMID: 14629816.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3845S-53S. Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL. PMID: 14506182.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    66. Documentation of idiotypic cascade after Lym-1 radioimmunotherapy in a patient with non-Hodgkin's lymphoma: basis for extended survival? Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):4007S-12S. Bradt BM, DeNardo SJ, Mirick GR, DeNardo GL. PMID: 14506201.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    67. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3854S-64S. DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, Lamborn KR, O'Donnell RT, DeNardo GL. PMID: 14506183.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    68. Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3865S-72S. DeNardo GL, DeNardo SJ, Peterson JJ, Miers LA, Lam KS, Hartmann-Siantar C, Lamborn KR. PMID: 14506184.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    69. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3938S-44S. DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. PMID: 14506192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. Characterization of human IgG antimouse antibody in patients with B-cell malignancies. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):4013S-21S. DeNardo GL, Mirick GR, Kroger LA, Bradt BM, Lamborn KR, DeNardo SJ. PMID: 14506202.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    71. Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy. J Nucl Med. 2003 Aug; 44(8):1322-9. Hartmann Siantar CL, DeNardo GL, DeNardo SJ. PMID: 12902424.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    72. Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs. Cancer Biother Radiopharm. 2003 Apr; 18(2):231-7. DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C, DeNardo S. PMID: 12804049.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Human antiglobulin response to foreign antibodies: therapeutic benefit? Cancer Immunol Immunother. 2003 May; 52(5):309-16. DeNardo GL, Bradt BM, Mirick GR, DeNardo S. PMID: 12700946; PMCID: PMC11034264.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    74. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy. Cancer Biother Radiopharm. 2003 Feb; 18(1):71-9. Descalle MA, Hartmann Siantar CL, Dauffy L, Nigg DW, Wemple CA, Yuan A, DeNardo GL. PMID: 12667310.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Blood. 2003 May 01; 101(9):3641-7. Tuscano JM, O'Donnell RT, Miers LA, Kroger LA, Kukis DL, Lamborn KR, Tedder TF, DeNardo GL. PMID: 12511412.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    76. Year 2002: the best year yet for CB&R. Cancer Biother Radiopharm. 2002 Dec; 17(6):599-600. DeNardo GL, Oldham RK. PMID: 12537663.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res. 2002 Aug 01; 62(15):4263-72. Burke PA, DeNardo SJ, Miers LA, Lamborn KR, Matzku S, DeNardo GL. PMID: 12154028.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimals
    78. Treatment planning for molecular targeted radionuclide therapy. Cancer Biother Radiopharm. 2002 Jun; 17(3):267-80. Siantar CH, Vetter K, DeNardo GL, DeNardo SJ. PMID: 12136519.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Rationales, evidence, and design considerations for fractionated radioimmunotherapy. Cancer. 2002 Feb 15; 94(4 Suppl):1332-48. DeNardo GL, Schlom J, Buchsbaum DJ, Meredith RF, O'Donoghue JA, Sgouros G, Humm JL, DeNardo SJ. PMID: 11877764.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    80. Combined modality radioimmunotherapy. Promise and peril. Cancer. 2002 Feb 15; 94(4 Suppl):1320-31. Burke PA, DeNardo SJ, Miers LA, Kukis DL, DeNardo GL. PMID: 11877763.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    81. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy. Cancer Biother Radiopharm. 2002 Feb; 17(1):107-18. DeNardo GL, Siantar CL, DeNardo SJ. PMID: 11915167.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. PMID: 11757033.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    83. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy. Cancer Biother Radiopharm. 2001 Dec; 16(6):525-35. DeNardo DG, Xiong CY, Shi XB, DeNardo GL, DeNardo SJ. PMID: 11789029.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    84. Year 2001: An Even Better Year for CB&R. Cancer Biotherapy & Radiopharmaceuticals. 2001 Dec 1; 16(6):449-450. Denardo DG, Oldham OR. .
      View in: Publisher Site   Mentions:
    85. Metabolite production in patients with lymphoma after radiometal-labeled antibody administration. J Nucl Med. 2001 Sep; 42(9):1324-33. DeNardo GL, DeNardo SJ, Kukis DL, O'Donnell RT, Shen S, Mirick GR, Meares CF. PMID: 11535720.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing. Crit Rev Oncol Hematol. 2001 Jul-Aug; 39(1-2):203-18. DeNardo GL, Juweid ME, White CA, Wiseman GA, DeNardo SJ. PMID: 11418317.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. PMID: 11410491.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
    88. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm. 2001 Jun; 16(3):213-25. Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ. PMID: 11471486.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    89. Radiolabeled anti-lymphoma antibodies. Cancer Chemother Biol Response Modif. 2001; 19:297-308. DeNardo GL, O'Donnell RT, DeNardo SJ. PMID: 11686019.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    90. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis. Cancer Biother Radiopharm. 2000 Dec; 15(6):547-60. DeNardo GL, DeNardo SJ, Wessels BW, Kukis DL, Miyao N, Yuan A. PMID: 11190487.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    91. Antibody phage display applications for nuclear medicine imaging and therapy. Q J Nucl Med. 2000 Sep; 44(3):284-95. Winthrop MD, Denardo GL, Denardo SJ. PMID: 11105591.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    92. A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. Anticancer Res. 2000 Sep-Oct; 20(5C):3647-55. O'Donnell RT, Shen S, Denardo SJ, Wun T, Kukis DL, Goldstein DS, Denardo GL. PMID: 11268433.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    93. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma. Clin Lymphoma. 2000 Sep; 1(2):118-26. DeNardo GL, DeNardo SJ, O'Donnell RT, Kroger LA, Kukis DL, Meares CF, Goldstein DS, Shen S. PMID: 11707820.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. PMID: 10906734.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    95. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. J Nucl Med. 2000 May; 41(5):952-8. DeNardo GL, O'Donnell RT, Shen S, Kroger LA, Yuan A, Meares CF, Kukis DL, DeNardo SJ. PMID: 10809213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. When is too much too much and yet not enough? Alas, a plethora of opportunities but where's the beef? J Nucl Med. 2000 Mar; 41(3):470-3. DeNardo GL. PMID: 10716321.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    97. Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy. Cancer Biother Radiopharm. 2000 Feb; 15(1):71-9. DeNardo SJ, Burke PA, Leigh BR, O'Donnell RT, Miers LA, Kroger LA, Goodman SL, Matzku S, Jonczyk A, Lamborn KR, DeNardo GL. PMID: 10740655.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    98. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma. J Nucl Med. 1999 Dec; 40(12):2014-20. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Carr CE, Mirick GR, DeNardo SJ. PMID: 10616879.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    99. Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body. J Nucl Med. 1999 Dec; 40(12):2102-6. Shen S, DeNardo GL, Sgouros G, O'Donnell RT, DeNardo SJ. PMID: 10616892.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    100. A new era for radiolabeled antibodies in cancer? Curr Opin Immunol. 1999 Oct; 11(5):563-9. DeNardo SJ, Kroger LA, DeNardo GL. PMID: 10508716.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    101. Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3010s-3014s. Kroger LA, DeNardo SJ, DeNardo GL, Xiong CY, Winthrop MD, Gumerlock PH. PMID: 10541336.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    102. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3088s-3094s. Winthrop MD, DeNardo SJ, DeNardo GL. PMID: 10541348.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    103. Strategies for developing effective radioimmunotherapy for solid tumors. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3219s-3223s. DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ. PMID: 10541367.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    104. Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3243s-3248s. Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. PMID: 10541370.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    105. Tribute to David A. Goodwin and Claude F. Meares, recipients of the Immunomedics Science Award. Clin Cancer Res. 1999 Oct; 5(10 Suppl):2992s-2993s. DeNardo GL. PMID: 10541332.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage. Cancer Biother Radiopharm. 1999 Oct; 14(5):363-9. Kukis DL, DeNardo SJ, Mills SL, Shen S, O'Donnell RT, DeNardo GL. PMID: 10850321.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    107. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3213s-3218s. DeNardo SJ, DeNardo GL, DeNardo DG, Xiong CY, Shi XB, Winthrop MD, Kroger LA, Carter P. PMID: 10541366.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    108. Determination of spleen size by scintigraphy. Cancer Biother Radiopharm. 1999 Oct; 14(5):407-11. Silverman S, DeNardo GL, Siegel E. PMID: 10850326.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3330s-3336s. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Mirick GR, DeNardo SJ. PMID: 10541382.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    110. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. Nucl Med Biol. 1999 Oct; 26(7):841-5. Mirick GR, O'Donnell RT, DeNardo SJ, Shen S, Meares CF, DeNardo GL. PMID: 10628566.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    111. Critical Lym-1 binding residues on polymorphic HLA-DR molecules. Mol Immunol. 1999 Aug; 36(11-12):789-97. Rose LM, Deng CT, Scott SL, Xiong CY, Lamborn KR, Gumerlock PH, DeNardo GL, Meares CF. PMID: 10593517.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    112. About the old and the new: gallium-67 scintigraphy to rituximab for lymphoma. Cancer Biother Radiopharm. 1999 Aug; 14(4):235-6. DeNardo GL. PMID: 10850308.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    113. Planar gamma camera quantitation of 123I, 99mTc or 111In in the liver and spleen of an abdominal phantom. Cancer Biother Radiopharm. 1999 Aug; 14(4):299-306. Macey DJ, DeNardo GL, DeNardo SJ. PMID: 10850316.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    114. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia. J Nucl Med. 1999 Aug; 40(8):1317-26. DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR. PMID: 10450684.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    115. Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma. Cancer Biother Radiopharm. 1999 Jun; 14(3):167-76. O'Donnell RT, Leigh BR, Christensen SD, Goldstein DS, Kukis DL, Shen S, Yuan A, DeNardo DA, Kroger LA, DeNardo GL. PMID: 10850301.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    116. Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragments. Cancer Biother Radiopharm. 1999 Apr; 14(2):139-43. Shi XB, Gumerlock PH, Kroger L, DeNardo GL, DeNardo SJ. PMID: 10850298.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    117. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy. Cancer Biother Radiopharm. 1999 Apr; 14(2):113-9. Leigh BR, Burke PA, Hong AM, O'Donnell RT, Howell LP, Miers LA, DeNardo GL, DeNardo SJ. PMID: 10850294.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    118. Dosimetry for radioimmunotherapy: a rapidly evolving field. Cancer Biother Radiopharm. 1999 Apr; 14(2):67-70. Wilder RB, Shen S, DeNardo GL. PMID: 10850289.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. "Historical Vignettes". Cancer Biother Radiopharm. 1999 Apr; 14(2):65-6. DeNardo GL, Oldham RK. PMID: 10917743.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Mar; 5(3):533-41. DeNardo GL, Kukis DL, Shen S, DeNardo DA, Meares CF, DeNardo SJ. PMID: 10100704.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    121. Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT. Hybridoma. 1999 Feb; 18(1):13-21. DeNardo SJ, DeNardo GL, Brush J, Carter P. PMID: 10211783.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    122. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma. J Nucl Med. 1999 Feb; 40(2):302-10. DeNardo SJ, DeNardo GL, Kukis DL, Shen S, Kroger LA, DeNardo DA, Goldstein DS, Mirick GR, Salako Q, Mausner LF, Srivastava SC, Meares CF. PMID: 10025839.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    123. Milestones in the development of Lym-1 therapy. Hybridoma. 1999 Feb; 18(1):1-11. DeNardo GL, O'Donnell RT, Rose LM, Mirick GR, Kroger LA, DeNardo SJ. PMID: 10211782.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCTClinical Trials
    124. Bone pain palliation. Cancer Biother Radiopharm. 1998 Dec; 13(6):407-11. DeNardo GL. PMID: 10851433.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    125. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates. J Nucl Med. 1998 Dec; 39(12):2105-10. Kukis DL, DeNardo SJ, DeNardo GL, O'Donnell RT, Meares CF. PMID: 9867151.
      View in: PubMed   Mentions: 11     Fields:    Translation:Cells
    126. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Res. 1998 Nov-Dec; 18(6A):4011-8. Denardo SJ, Richman CM, Kukis DL, Shen S, Lamborn KR, Miers LA, Kroger LA, Perez EA, Denardo GL. PMID: 9891439.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    127. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clin Cancer Res. 1998 Oct; 4(10):2483-90. DeNardo GL, Kroger LA, Meares CF, Richman CM, Salako Q, Shen S, Lamborn KR, Peterson JJ, Miers LA, Zhong GR, DeNardo SJ. PMID: 9796981.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    128. Biotherapy of cancer marches on! Cancer Biother Radiopharm. 1998 Oct; 13(5):335-6. DeNardo GL. PMID: 10851423.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts. Cancer Biother Radiopharm. 1998 Oct; 13(5):351-61. O'Donnell RT, DeNardo SJ, Miers LA, Kukis DL, Mirick GR, Kroger LA, DeNardo GL. PMID: 10851425.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    130. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol. 1998 Oct; 16(10):3246-56. DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, Lamborn KR, Levy NB, McGahan JP, Salako Q, Shen S, Lewis JP. PMID: 9779698.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    131. L6 monoclonal antibody binds prostate cancer. Prostate. 1998 Oct 01; 37(2):91-7. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. PMID: 9759703.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    132. A revolution in the treatment of non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 1998 Aug; 13(4):213-23. DeNardo GL, O'Donnell RT, Oldham RK, DeNardo SJ. PMID: 10850358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    133. Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody. Cancer Biother Radiopharm. 1998 Aug; 13(4):239-54. DeNardo GL, DeNardo SJ, Lamborn KR, Goldstein DS, Levy NB, Lewis JP, O'Grady LF, Raventos A, Kroger LA, Macey DJ, McGahan JP, Mills SL, Shen S. PMID: 10850360.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    134. A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy. J Nucl Med. 1998 Jul; 39(7):1223-9. Shen S, DeNardo GL, Jones TD, Wilder RB, O'Donnell RT, DeNardo SJ. PMID: 9669399.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    135. Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study. Anticancer Res. 1998 Jul-Aug; 18(4B):2779-88. Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF. PMID: 9713461.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    136. Quantification of iodine-131 in tumors using a threshold based on image contrast. Eur J Nucl Med. 1998 May; 25(5):497-502. DeNardo GL, Shen S, DeNardo SJ, Liao SQ, Lamborn KR, DeNardo DA, Yuan A. PMID: 9575245.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    137. Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts. J Nucl Med. 1998 May; 39(5):842-9. DeNardo SJ, Kukis DL, Miers LA, Winthrop MD, Kroger LA, Salako Q, Shen S, Lamborn KR, Gumerlock PH, Meares CF, DeNardo GL. PMID: 9591587.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    138. New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor. Hybridoma. 1998 Apr; 17(2):125-32. Feng X, Pak RH, Kroger LA, Moran JK, DeNardo DG, Meares CF, DeNardo GL, DeNardo SJ. PMID: 9627052.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    139. Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody. Cancer Biother Radiopharm. 1998 Feb; 13(1):1-12. DeNardo SJ, Kroger LA, MacKenzie MR, Mirick GR, Shen S, DeNardo GL. PMID: 10850337.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    140. Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies. Cancer. 1997 Dec 15; 80(12 Suppl):2553-7. Shen S, DeNardo GL, O'Donnell RT, Yuan A, DeNardo DA, DeNardo SJ. PMID: 9406709.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Imaging for improved prediction of myelotoxicity after radioimmunotherapy. Cancer. 1997 Dec 15; 80(12 Suppl):2558-66. DeNardo DA, DeNardo GL, O'Donnell RT, Lim SM, Shen S, Yuan A, DeNardo SJ. PMID: 9406710.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    142. Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2728-32. Richman CM, Schuermann TC, Wun T, Malik R, O'Donnell RT, DeNardo GL, DeNardo SJ. PMID: 9406731.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Tribute to Ralph A. Reisfeld, Ph.D. Cancer. 1997 Dec 15; 80(12 Suppl):2345-6. DeNardo GL. PMID: 9406681.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    144. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. PMID: 9406712.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    145. Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Cancer. 1997 Dec 15; 80(12 Suppl):2706-11. DeNardo GL, Lamborn KR, Goldstein DS, Kroger LA, DeNardo SJ. PMID: 9406728.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    146. Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2583-90. DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. PMID: 9406713.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    147. Prediction of myelotoxicity using semi-quantitative marrow image scores. J Nucl Med. 1997 Nov; 38(11):1749-53. Lim S, DeNardo GL, DeNardo DA, O'Donnell RT, Yuan A, DeNardo SJ. PMID: 9374345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources. J Nucl Med. 1997 Sep; 38(9):1374-8. Lim SM, DeNardo GL, DeNardo DA, Shen S, Yuan A, O'Donnell RT, DeNardo SJ. PMID: 9293790.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    149. Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies. Clin Cancer Res. 1997 Aug; 3(8):1253-60. Lamborn KR, DeNardo GL, DeNardo SJ, Goldstein DS, Shen S, Larkin EC, Kroger LA. PMID: 9815807.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    150. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med. 1997 Aug; 38(8):1180-5. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL. PMID: 9255145.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    151. Practical determination of organ S values for individual patients for therapy. Nucl Med Biol. 1997 Jul; 24(5):447-9. Shen S, DeNardo GL, Macey DJ, O'Donnell RT, Yuan A, DeNardo DA, DeNardo SJ. PMID: 9290081.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    152. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. PMID: 9179227.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    153. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody. Anticancer Res. 1997 May-Jun; 17(3B):1745-51. Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. PMID: 9179228.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCTClinical Trials
    154. Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. Proc Natl Acad Sci U S A. 1997 Apr 15; 94(8):4000-4. DeNardo SJ, Kukis DL, Kroger LA, O'Donnell RT, Lamborn KR, Miers LA, DeNardo DG, Meares CF, DeNardo GL. PMID: 9108094; PMCID: PMC20557.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    155. Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth. Biochem Mol Med. 1997 Apr; 60(2):108-15. Morris G, DeNardo SJ, DeNardo GL, Leshchinsky T, Wu B, Mack PC, Winthrop MD, Gumerlock PH. PMID: 9169090.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    156. Reproducibility of operator processing for radiation dosimetry. Nucl Med Biol. 1997 Jan; 24(1):77-83. Shen S, DeNardo GL, DeNardo SJ, Yuan A, DeNardo DA, Lamborn KR. PMID: 9080478.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    157. Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji). Clin Cancer Res. 1997 Jan; 3(1):71-9. DeNardo GL, Kukis DL, Shen S, Mausner LF, Meares CF, Srivastava SC, Miers LA, DeNardo SJ. PMID: 9815540.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    158. Trials and tribulations: oncological antibody imaging comes to the fore. Semin Nucl Med. 1997 Jan; 27(1):10-29. Zuckier LS, DeNardo GL. PMID: 9122720.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    159. Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies. J Nucl Med. 1996 Dec; 37(12):1970-5. DeNardo DA, DeNardo GL, Yuan A, Shen S, DeNardo SJ, Macey DJ, Lamborn KR, Mahe M, Groch MW, Erwin WD. PMID: 8970516.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    160. Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10. Cancer Immunol Immunother. 1996 Sep; 43(1):26-30. Rose LM, Gunasekera AH, DeNardo SJ, DeNardo GL, Meares CF. PMID: 8917632.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    161. Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy. Eur J Nucl Med. 1996 Aug; 23(8):953-7. Wilder RB, DeNardo GL, Sheri S, Fowler JF, Wessels BW, DeNardo SJ. PMID: 8753685.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    162. Potential use of amino acid cocktails to reduce renal tubular reabsorption of radioconjugates. J Nucl Med. 1996 May; 37(5):837-8. DeNardo SJ, O'Donnell RT, DeNardo GL. PMID: 8965156.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    163. A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy. Nucl Med Biol. 1996 May; 23(4):525-32. Erwin WD, Groch MW, Macey DJ, DeNardo GL, DeNardo SJ, Shen S. PMID: 8832711.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    164. Radioimmunotherapy: recent results and future directions. J Clin Oncol. 1996 Apr; 14(4):1383-400. Wilder RB, DeNardo GL, DeNardo SJ. PMID: 8648397.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    165. Antibody responses to macrocycles in lymphoma. J Nucl Med. 1996 Mar; 37(3):451-6. DeNardo GL, Mirick GR, Kroger LA, O'Donnell RT, Meares CF, DeNardo SJ. PMID: 8772643.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    166. Accurate measurement of copper-67 in the presence of copper-64 contaminant using a dose calibrator. J Nucl Med. 1996 Feb; 37(2):302-6. DeNardo GL, Kukis DL, Shen S, DeNardo SJ. PMID: 8667066.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy. J Nucl Med. 1996 Jan; 37(1):146-50. Shen S, DeNardo GL, DeNardo SJ, Salako Q, Morris G, Banks D, Yuan A, DeNardo DA. PMID: 8543984.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    168. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 1995 Dec 01; 55(23 Suppl):5916s-5920s. Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL. PMID: 7493370.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    169. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res. 1995 Dec 01; 55(23 Suppl):5837s-5841s. DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. PMID: 7493356.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    170. Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies. Cancer Res. 1995 Dec 01; 55(23 Suppl):5893s-5898s. DeNardo GL, Lamborn KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. PMID: 7493366.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    171. Immunohistochemical staining of metastatic ductal carcinomas of the breast by monoclonal antibodies used in imaging and therapy: A comparative study. Int J Biol Markers. 1995 Jul-Sep; 10(3):129-35. Howell LP, DeNardo SJ, Levy NB, Lund J, DeNardo GL. PMID: 8551054.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    172. Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. J Nucl Med. 1995 May; 36(5):754-61. Breitz HB, Durham JS, Fisher DR, Weiden PL, DeNardo GL, Goodgold HM, Nelp WB. PMID: 7738644.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    173. Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice. J Nucl Med. 1995 May; 36(5):829-36. DeNardo SJ, Zhong GR, Salako Q, Li M, DeNardo GL, Meares CF. PMID: 7738660.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    174. Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1. Int J Biol Markers. 1995 Apr-Jun; 10(2):67-74. De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. PMID: 7561241.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    175. Radioimmunotherapy of lymphoma: a UC Davis experience. Hybridoma. 1995 Apr; 14(2):115-20. Lewis JP, Denardo GL, Denardo SJ. PMID: 7590765.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    176. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res. 1995 Feb 15; 55(4):878-84. Kukis DL, DeNardo GL, DeNardo SJ, Mirick GR, Miers LA, Greiner DP, Meares CF. PMID: 7850803.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    177. Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy. Clin Nucl Med. 1995 Feb; 20(2):117-25. Macey DJ, DeNardo SJ, DeNardo GL, DeNardo DA, Shen S. PMID: 7720301.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    178. Treatment of cancer with intratumoral infusion of radioisotopes. Int J Radiat Oncol Biol Phys. 1994 Oct 15; 30(3):737-9; discussion 745-6. Wilder RB, Denardo GL, Denardo SJ. PMID: 7928510.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    179. Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med Phys. 1994 Sep; 21(9):1409-17. Shen S, DeNardo GL, DeNardo SJ. PMID: 7838052.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    180. Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med. 1994 Aug; 35(8):1381-9. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ. PMID: 8046498.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    181. Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia. Cancer. 1994 Mar 01; 73(5):1425-32. DeNardo GL, Lewis JP, DeNardo SJ, O'Grady LF. PMID: 8111709.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    182. The biologic window for chimeric L6 radioimmunotherapy. Cancer. 1994 Feb 01; 73(3 Suppl):1023-32. DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, Lamborn KR, Hellstrom I, Hellstrom KE, DeNardo GL. PMID: 8306244.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    183. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer. 1994 Feb 01; 73(3 Suppl):779-86. Kukis DL, Diril H, Greiner DP, DeNardo SJ, DeNardo GL, Salako QA, Meares CF. PMID: 8306260.
      View in: PubMed   Mentions: 15     Fields:    
    184. Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer. 1994 Feb 01; 73(3 Suppl):1012-22. DeNardo GL, Kroger LA, DeNardo SJ, Miers LA, Salako Q, Kukis DL, Fand I, Shen S, Renn O, Meares CF. PMID: 8306243.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    185. Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model. Cancer. 1994 Feb 01; 73(3 Suppl):1038-48. DeNardo GL, DeNardo SJ, Macey DJ, Shen S, Kroger LA. PMID: 8306246.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    186. Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6. Adv Exp Med Biol. 1994; 353:203-11. DeNardo SJ, O'Grady LF, Richman CM, DeNardo GL. PMID: 7527179.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCTClinical Trials
    187. Use of response surface statistical designs to detect effects of biologic response modifiers such as IL-2. Biotechnol Ther. 1994; 5(1-2):15-26. DeNardo GL, Lamborn KR, DeNardo SJ, Kroger LA. PMID: 7703830.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    188. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl. 1993 Aug; 3(1):46-53. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. PMID: 8220184.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    189. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J Nucl Med. 1993 Jul; 34(7):1067-74. Kramer EL, DeNardo SJ, Liebes L, Kroger LA, Noz ME, Mizrachi H, Salako QA, Furmanski P, Glenn SD, DeNardo GL, et al. PMID: 8315480.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    190. Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies. Nucl Med Commun. 1993 Jul; 14(7):587-95. DeNardo GL, Mahe MA, DeNardo SJ, Macey DJ, Mirick GR, Erwin WD, Groch MW. PMID: 8355919.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. Immunoadsorption: an enhancement strategy for radioimmunotherapy. J Nucl Med. 1993 Jun; 34(6):1020-7. DeNardo GL, Maddock SW, Sgouros G, Scheibe PO, DeNardo SJ. PMID: 8509840.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    192. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors. J Neurosurg. 1992 Nov; 77(5):694-9. Quattrocchi KB, Miller CH, Wagner FC, DeNardo SJ, DeNardo GL, Ovodov K, Frank EH. PMID: 1403109.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    193. Enhancement of clinical radioimmunotherapy for cancer and the role of cytokines. J Natl Cancer Inst. 1992 Mar 18; 84(6):374-5. DeNardo SJ, DeNardo GL, Richman CM. PMID: 1538409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    194. Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibody. Int J Biol Markers. 1991 Oct-Dec; 6(4):221-30. DeNardo SJ, Warhoe KA, O'Grady LF, Hellstrom I, Hellstrom KE, Mills SL, Macey DJ, Goodnight JE, DeNardo GL. PMID: 1665501.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    195. Strategies for enhancement of radioimmunotherapy. Int J Rad Appl Instrum B. 1991; 18(6):633-40. DeNardo G, DeNardo S, Kukis D, Diril H, Suey C, Meares C. PMID: 1743986.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    196. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Int J Rad Appl Instrum B. 1991; 18(6):621-31. DeNardo SJ, O'Grady LF, Macey DJ, Kroger LA, DeNardo GL, Lamborn KR, Levy NB, Mills SL, Hellstrom I, Hellstrom KE. PMID: 1743985.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    197. Quo vadis radioimmune imaging? J Nucl Med. 1990 Aug; 31(8):1439-42. DeNardo GL, DeNardo SJ. PMID: 2384818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    198. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med. 1990 Apr; 31(4):473-9. Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF. PMID: 2324823.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    199. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. J Nucl Med. 1990 Feb; 31(2):218-24. Deshpande SV, Subramanian R, McCall MJ, DeNardo SJ, DeNardo GL, Meares CF. PMID: 2107283.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    200. Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1. Cancer Res. 1990 Feb 01; 50(3 Suppl):1014s-1016s. DeNardo GL, DeNardo SJ, O'Grady LF, Levy NB, Adams GP, Mills SL. PMID: 2297713.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    201. A treatment planning program for radioimmunotherapy. Front Radiat Ther Oncol. 1990; 24:123-31; discussion 161-5. Macey DJ, DeNardo GL, DeNardo SJ. PMID: 2341047.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    202. Radiation treatment of B cell malignancies with immunoconjugate. Front Radiat Ther Oncol. 1990; 24:194-201; discussion 202-3. DeNardo GL, DeNardo SJ, O'Grady LF, Mills SL, Lewis JP, Macey DJ. PMID: 2341050.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    203. Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer. Front Radiat Ther Oncol. 1990; 24:142-50; discussion 161-5. DeNardo SJ, Deshpande SV, Moi MK, Adamas GP, McCall MK, DeNardo GL, Meares CF. PMID: 2341049.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    204. Current status of immunoscintigraphy in the detection of thrombosis and thromboembolism. Semin Nucl Med. 1989 Jul; 19(3):221-37. Koblik PD, De Nardo GL, Berger HJ. PMID: 2669130.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    205. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice. Cancer Res. 1989 Apr 01; 49(7):1707-11. Adams GP, DeNardo SJ, Deshpande SV, DeNardo GL, Meares CF, McCall MJ, Epstein AL. PMID: 2493983.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    206. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Int J Rad Appl Instrum B. 1989; 16(6):587-97. Deshpande SV, Denardo SJ, Meares CF, McCall MJ, Adams GP, Denardo GL. PMID: 2606714.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    207. Quantitative SPECT of uptake of monoclonal antibodies. Semin Nucl Med. 1989 Jan; 19(1):22-32. DeNardo GL, Macey DJ, DeNardo SJ, Zhang CG, Custer TR. PMID: 2652304.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    208. Pharmaceutical quality control of radiolabeled monoclonal antibodies and their fragments. Am J Physiol Imaging. 1989; 4(1):39-44. DeNardo SJ, DeNardo GL, Peng JS. PMID: 2647112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    209. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med. 1988 Nov; 29(11):1795-809. Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. PMID: 3263479.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    210. Breast cancer imaging with In-111 human IgM monoclonal antibodies: preliminary studies. Radiology. 1988 Apr; 167(1):71-5. Ryan KP, Dillman RO, DeNardo SJ, DeNardo GL, Beauregard J, Hagan PL, Amox DG, Clutter ML, Burnett KG, Rulot CM, et al. PMID: 3347750.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    211. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. J Nucl Med. 1988 Feb; 29(2):217-25. Deshpande SV, DeNardo SJ, Meares CF, McCall MJ, Adams GP, Moi MK, DeNardo GL. PMID: 3258025.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    212. Comparison of three boundary detection methods for SPECT using Compton scattered photons. J Nucl Med. 1988 Feb; 29(2):203-7. Macey DJ, DeNardo GL, DeNardo SJ. PMID: 3258024.
      View in: PubMed   Mentions: 4     Fields:    
    213. Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies. Int J Cancer Suppl. 1988; 3:96-101. DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL. PMID: 3209308.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    214. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma. Am J Physiol Imaging. 1988; 3(1):1-6. Macey DJ, Denardo SJ, Denardo GL, Goodnight JK, Unger MW. PMID: 3390350.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    215. Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies. Int J Biol Markers. 1988 Jan-Mar; 3(1):1-9. De Nardo GL, De Nardo SJ, Miyao NP, Mills SL, Peng JS, O'Grady LF, Epstein AL, Young WC. PMID: 3249042.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    216. Prospects for radiolabeled monoclonal antibodies in metastatic disease. J Thorac Imaging. 1987 Oct; 2(4):44-9. Raventos A, DeNardo SJ, DeNardo G. PMID: 3316685.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J Nucl Med. 1987 Jan; 28(1):83-90. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. PMID: 3794813.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    218. Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies. Int J Biol Markers. 1987 Jan-Apr; 2(1):49-53. DeNardo SJ, DeNardo GL, O'Grady LF, Macey DJ, Mills SL, Epstein AL, Peng JS, McGahan JP. PMID: 3501448.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    219. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies. J Nucl Med. 1986 Sep; 27(9):1467-74. Macey DJ, DeNardo GL, DeNardo SJ, Hines HH. PMID: 3489084.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    220. Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. J Nucl Med. 1986 Aug; 27(8):1243-54. Koizumi K, DeNardo GL, DeNardo SJ, Hays MT, Hines HH, Scheibe PO, Peng JS, Macey DJ, Tonami N, Hisada K. PMID: 3488377.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    221. Radiolabelled monoclonal antibodies for the detection of cancer. Am J Physiol Imaging. 1986; 1(1):44-53. O'Grady LF, DeNardo G, DeNardo S. PMID: 3330440.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    222. Serum stability of 67Cu chelates: comparison with 111In and 57Co. Int J Rad Appl Instrum B. 1986; 13(4):363-8. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. PMID: 3539884.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    223. Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development. Int J Rad Appl Instrum B. 1986; 13(4):303-10. DeNardo SJ, Peng JS, DeNardo GL, Mills SL, Epstein AL. PMID: 3466890.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    224. 123I radiolabeling of monoclonal antibodies for in vivo procedures. Hybridoma. 1986; 5(4):265-75. Mills SL, Denardo SJ, Denardo GL, Epstein AL, Peng JS, Colcher D. PMID: 3542804.
      View in: PubMed   Mentions: 3     Fields:    
    225. Correlation of bioscintigraphy, contrast venography, and iodine-125 fibrinogen uptake test. Clin Nucl Med. 1985 Dec; 10(12):880-3. DeNardo GL, DeNardo SJ, Carretta RF, Bogren HG, Jansholt AL, Krohn KA, Peek NF. PMID: 4075688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    226. Detection of thrombophlebitis in the lower extremities: a regional comparison of 123I fibrinogen scintigraphy and contrast venography. AJR Am J Roentgenol. 1985 Nov; 145(5):1045-52. DeNardo SJ, Bogren HG, DeNardo GL. PMID: 3876735.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. 31P surface-coil NMR analysis of metabolic status in KHJJ tumors. Magn Reson Med. 1985 Oct; 2(5):419-27. Adams DA, DeNardo GL, DeNardo SJ, Conboy CB, Bradbury EM. PMID: 4094556.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    228. Radioimmunotherapy of human lymphoma in athymic, nude mice as monitored by 31P nuclear magnetic resonance. Biochem Biophys Res Commun. 1985 Sep 16; 131(2):1020-7. Adams DA, DeNardo GL, DeNardo SJ, Matson GB, Epstein AL, Bradbury EM. PMID: 3876832.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    229. Requirements for a treatment planning system for radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1985 Feb; 11(2):335-48. DeNardo GL, Raventos A, Hines HH, Scheibe PO, Macey DJ, Hays MT, DeNardo SJ. PMID: 3882643.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    230. Bronchoscopic location of bronchopleural fistula with xenon-133. J Nucl Med. 1982 Apr; 23(4):322-3. Lillington GA, Stevens RP, DeNardo GL. PMID: 7069496.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    231. Thrombosis detection: fibrinogen counting and radionuclide venography. Clin Nucl Med. 1981 Oct; 6(10S):P37-45. DeNardo GL, DeNardo SJ. PMID: 7296993.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Noninvasive measurement of pulmonary transvascular protein flux in normal man. J Clin Invest. 1980 Nov; 66(5):869-77. Gorin AB, Kohler J, DeNardo G. PMID: 7430349; PMCID: PMC371520.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    233. Immediate renal imaging and renography with 99mTc methylene diphosphonate to assess renal blood flow, excretory function, and anatomy. Radiology. 1980 Apr; 135(1):187-90. Glass EC, DeNardo GL, Hines HH. PMID: 7360959.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    234. Nuclear medicine-epitomes of progress: iodine 125 fibrinogen uptake test. West J Med. 1978 Nov; 129(5):415-6. Denardo GL, Denardo SJ. PMID: 18748320; PMCID: PMC1238400.
      View in: PubMed   Mentions:    Fields:    
    235. Abnormal peripheral distribution of Thallium-201 due to arteriosclerosis. AJR Am J Roentgenol. 1978 Oct; 131(4):718-20. Glass EC, DeNardo GL. PMID: 102170.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    236. Catabolism and protein binding of Tc-99m pyridoxylideneglutamate. J Nucl Med. 1978 Sep; 19(9):1036-44. Jansholt AL, Krohn KA, Stadalnik RC, Matolo NM, DeNardo GL. PMID: 99499.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    237. Clinical assessment of combined organ imaging in the diagnosis of subphrenic abscesses. Clin Nucl Med. 1978 Mar; 3(3):113-5. Salamanca JE, Stadalnik RC, DeNardo GL. PMID: 657664.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    238. Definitive diagnosis of choledochal cyst by 99mTc-pyridoxylideneglutamate sequential scintiphotography. Clin Nucl Med. 1978 Feb; 3(2):49-52. Yeh SH, Stadalnik RC, DeNardo GL, Chau WK. PMID: 657652.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    239. Production and characteristics of 81Rb for myocardial studies. Int J Nucl Med Biol. 1978; 5(6):273-8. Peek NF, Hegedus F, DeNardo GL, Lagunas-Solar M, Berman DS. PMID: 738843.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    240. Isotope imaging in the diagnosis of primary and secondary tumors of the liver. Prog Clin Cancer. 1978; 7:165-80. Stadalnik RC, DeNardo GL. PMID: 212781.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    241. Scintigraphy in the diagnosis of osteonecrosis. Clin Orthop Relat Res. 1978 Jan-Feb; (130):139-43. D'Ambrosia RD, Shoji H, Riggins RS, Stadalnik RC, DeNardo GL. PMID: 639385.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    242. Assessment of conventional criteria for the early diagnosis of thrombophlebitis with the 125I-fibrinogen uptake test. Radiology. 1977 Dec; 125(3):765-8. DeNardo GL, DeNardo SJ, Barnett CA, Newcomer KA, Jansholt AL, Carretta RF, Rose AW. PMID: 928706.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    243. Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga-citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice. Cancer. 1977 Dec; 40(6):2923-9. DeNardo GL, Krohn KA, DeNardo SJ. PMID: 73412.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    244. Problem of diffuse cardiac uptake of technetium-99m pyrophosphate in the diagnosis of acute myocardial infarction: enhanced scintigraphic accuracy by computerized selective blood pool subtraction. Am J Cardiol. 1977 Nov; 40(5):768-74. Berman DS, Amsterdam EA, Hines HH, Denardo GL, Salel AF, Ikeda R, Jansholt AL, Mason DT. PMID: 200134.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    245. I-fibrinogen as an oncophilic radiodiagnostic agent: distribution kinetics in tumour-bearing mice. Br J Cancer. 1977 Aug; 36(2):227-34. Krohn KA, DeNardo SJ, Wheeler DW, DeNardo GL. PMID: 911661; PMCID: PMC2025464.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    246. Detection of anticoagulation therapy failures in patients with venous thrombosis. Am J Surg. 1977 Aug; 134(2):214-6. Pollak EW, DeNardo S, Pollak M, DeNardo G, Wolfman EF. PMID: 889034.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    247. Iodine-123-fibrinogen scintigraphy. Semin Nucl Med. 1977 Jul; 7(3):245-51. DeNardo SJ, DeNardo GL. PMID: 887945.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    248. Radioactive labeling of protein carboxyl groups on factor VIII: use of carbodiimides for nuclear medicine. J Nucl Med. 1977 May; 18(5):472-7. DeNardo SJ, Hershgold EJ, DeNardo GL, Krohn KA, Godin DR. PMID: 859025.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    249. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice. J Nucl Med. 1977 Mar; 18(3):276-81. Krohn KA, Meyers JM, DeNardo GL, DeNardo SJ. PMID: 65460.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    250. New approach to interpretation of technetium-99m pyrophosphate scintigraphy in detection of acute myocardial infarction: clinical assessment of diagnostic accuracy. Am J Cardiol. 1977 Mar; 39(3):341-6. Berman DS, Amsterdam EA, Hines HH, Salel AF, Bailey GJ, DeNardo GL, Mason DT. PMID: 320857.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    251. Evaluation of myocardial uptake of 99mtechnetium pyrophosphate in clinical exercise-induced ventricular ischemia. Chest. 1977 Mar; 71(3):349-53. Berman DS, Salel AF, Amsterdam EA, DeNardo GL, Mason DT. PMID: 189975.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    252. Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice. Radiology. 1977 Jan; 122(1):179-82. Krohn KA, Meyers J, DeNardo GL. PMID: 63131.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    253. Early diagnosis of venous thrombosis using 125I-fibrinogen. J Nucl Med. 1977 Jan; 18(1):5-10. Carretta RF, DeNardo SJ, DeNardo GL, Janshalt AL, Rose AW. PMID: 830829.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    254. Determination of improved myocardial perfusion after aortocoronary bypass surgery by exercise rubidium-81 scintigraphy. Circulation. 1976 Dec; 54(6 Suppl):III20-3. Lurie AJ, Salel AF, Berman DS, DeNardo GL, Hurley EJ, Mason DT. PMID: 1086743.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    255. Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy. Radiology. 1976 Dec; 121(3 Pt. 1):657-61. Stadalnik RC, Matolo NM, Jansholt AL, Krohn KA, DeNardo GL, Wolfman EF. PMID: 981662.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    256. Vascularity of the femoral head. Tc diphosphonate scintigraphy validated with tetracycline labeling. Clin Orthop Relat Res. 1976 Nov-Dec; (121):143-8. D'Ambrosia RD, Riggins RS, Stadalnik RC, DeNardo GL. PMID: 991494.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    257. A new constant infusion radioisotopic technique for the noninvasive determination of cardiac output. Med Instrum. 1976 Jul-Aug; 10(4):195-204. Berman DS, Salel AF, DeNardo GL, Bell GB, Scheibe PO, Jackson PE, Mason DT. PMID: 785164.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    258. Radionuclide assessment of nitroglycerin influence on abnormal left ventricular segmental contraction in patients with coronary heart disease. Circulation. 1976 Jun; 53(6):975-82. Salel AF, Berman DS, DeNardo GL, Mason DT. PMID: 817850.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    259. Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography. Ann Intern Med. 1976 Jun; 84(6):700-3. Miller RR, Lies JE, Carretta RF, Wampold DB, DeNardo GL, Kraus JF, Amsterdam EA, Mason DT. PMID: 937882.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    260. Diagnosis of cirrhosis and hepatitis by quantitative hepatic and other reticuloendothelial clearance rates. J Nucl Med. 1976 Jun; 17(6):449-59. DeNardo SJ, Bell GB, DeNardo GL, Carretta RF, Scheibe PO, Imperato TJ, Jackson PE. PMID: 1262962.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    261. Noninvasive detection of regional myocardial ischemia using rubidium-81 and the scintillation camera: comparison with stress electrocardiography in patients with arteriographically documented coronary stenosis. Circulation. 1975 Oct; 52(4):619-26. Berman DS, Salel AF, DeNardo GL, Mason DT. PMID: 1157274.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    262. Letter: "Polyphosphate bone scans, 32phosphorus, and adenocarcinoma of the thyroid". J Nucl Med. 1975 Oct; 16(10):963-4. Denardo GL. PMID: 1177037.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    263. Clinical assessment of left ventricular regional contraction patterns and ejection fraction by high-resolution gated scintigraphy. J Nucl Med. 1975 Oct; 16(10):865-74. Berman DS, Salel AF, DeNardo GL, Bogren HG, Mason DT. PMID: 809551.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    264. Preparation and chemical characterization of radioiodinated bleomycin. J Nucl Med. 1975 Sep; 16(9):835-8. Meyers J, Krohn K, DeNardo G. PMID: 51079.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    265. Critical evaluation of hepatic scintiangiography for neoplastic tumors of the liver. J Nucl Med. 1975 Jul; 16(7):595-601. Stadalnik RC, DeNardo SJ, DeNardo GL, Raventos A. PMID: 168325.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    266. Scintigraphic imaging of a blind-ending ureteral duplication. J Nucl Med. 1975 Mar; 16(3):208-9. Bublin AB, Stadalnik RC, DeNardo GL, Vogel JM. PMID: 1113169.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    267. Vascularity of the femoral head: 18fluorine scintigraphy validated with tetracycline labeling. Radiology. 1975 Mar; 114(3):663-6. Stadalnik RC, Riggins RL, D'Ambrosia R, DeNardo GL. PMID: 1118569.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    268. Production and characteristics of 125Xe: a new noble gas for in vivo studies. J Nucl Med. 1975 Feb; 16(2):143-7. Hines HH, Peek NF, DeNardo GL, Jansholt AL. PMID: 1110419.
      View in: PubMed   Mentions:    Fields:    
    269. Pharmacokinetics of radioiodinated streptokinase. J Nucl Med. 1975 Feb; 16(2):136-42. Coates G, DeNardo SJ, DeNardo GL, Troy FA. PMID: 1110418.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    270. Fluoride-18 scintigraphy in avascular necrotic disorders of bone. Clin Orthop Relat Res. 1975; (107):146-55. D'Ambrosia RD, Riggins RS, DeNardo SJ, DeNardo GL. PMID: 1132172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    271. Experience with 99mTc diphosphonate in studying vascularity of the femoral head. Surg Forum. 1975; 26:521-3. D'Ambrosia RD, Riggins RS, Stadalnik RC, DeNardo GL. PMID: 1216213.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    272. Hepatic scintiangiographic patterns. Radiology. 1974 Apr; 111(1):135-41. DeNardo GL, Stadalnik RC, DeNardo SJ, Raventos A. PMID: 4361195.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    273. Assessment of circulation in the femoral head by 18F scintigraphy. J Nucl Med. 1974 Mar; 15(3):183-6. Riggins RS, DeNardo GL, D'Ambrosia R, Goldman M. PMID: 4813225.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    274. Hepatic scintiangiography in malignant parasitic tumors. J Nucl Med. 1974 Feb; 15(2):137-9. Coates G, Stadalnik RC, Palmer JM, DeNardo GL. PMID: 4810586.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    275. Bone marrow and bone mineral scintigraphic studies in sickle cell disease. Br J Haematol. 1973 Nov; 25(5):593-8. Hammel CF, DeNardo SJ, DeNardo GL, Lewis JP. PMID: 4753225.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    276. 18-F scintigraphy in diagnosis and management of avascular necrosis bone disorders. Surg Forum. 1973; 24:473-4. D'Ambrosia RD, Riggins RS, DeNardo G. PMID: 4806068.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    277. Regional distribution of feline esophageal blood flow. Gastroenterology. 1972 Oct; 63(4):627-33. Harell GS, DeNardo GL, Archibald RW, Bradley BR, Zboralske FF. PMID: 4562019.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    278. Production of carrier-free 123 I using the 127 I(p,5n) 123 Xe reaction. J Nucl Med. 1972 Oct; 13(10):729-32. Fusco MA, Peek NF, Jungerman JA, Zielinski FW, DeNardo SJ, DeNardo GL. PMID: 5056687.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    279. Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med. 1972 Jul; 117(1):1-7. Gnekow WC, DeNardo GL, Poole GJ, Kriss JP. PMID: 5039800; PMCID: PMC1518464.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    280. Evaluation of the liver and spleen in Hodgkin's disease. I. The value of hepatic scintigraphy. Am J Med. 1972 Mar; 52(3):356-61. Lipton MJ, DeNardo GL, Silverman S, Glatstein E. PMID: 5011393.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    281. Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133. Cancer Res. 1972 Mar; 32(3):483-90. Kallman RF, DeNardo GL, Stasch MJ. PMID: 5061303.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    282. Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphy. Am J Med. 1972 Mar; 52(3):362-6. Silverman S, DeNardo Gl, Glatstein E, Lipton MJ. PMID: 5011394.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    283. Cyclotron production of carrier-free 123 I using the reaction 127 I (p, 5n) 123 Xe. Strahlentherapie Sonderb. 1972; 72:367-75. Fusco MA, Peek NF, Jungermann JA, Zielinski FW, DeNardo SJ, DeNardo GL. PMID: 4659353.
      View in: PubMed   Mentions:    Fields:    
    284. Effects of changes of canine portal vein flow on hepatic artery hemodynamics. Surg Forum. 1972; 23(0):354-6. Walsh HG, Stasch MJ, DeNardo GL, Crowley LG. PMID: 4671115.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    285. 85 Sr bone scan in neoplastic disease. Semin Nucl Med. 1972 Jan; 2(1):18-30. DeNardo GL, Jacobson SJ, Raventos A. PMID: 4501055.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    286. The diagnostic value of brain scanning in intracranial lymphomas. Radiology. 1972 Jan; 102(1):111-6. Thompson RW, DeNardo GL, Kottra JJ. PMID: 4550313.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    287. Localization of strontium 85 in soft tissue infected by Aspergillus niger. Radiology. 1971 Oct; 101(1):119-23. Ray GR, DeNardo GL, King GH. PMID: 5111964.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    288. Distribution of blood flow to the muscle and mucosa of the rat esophagus. Invest Radiol. 1971 Jul-Aug; 6(4):255-9. Zboralske FF, Harell GS, DeNardo GL, Bradley B. PMID: 4935917.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    289. Enhanced scintigraphic information display using computer-generated ratio techniques. J Nucl Med. 1970 Nov; 11(11):655-9. Bell RL, DeNardo GL. PMID: 5476926.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    290. Cerebrospinal-fluid dynamics. N Engl J Med. 1970 Oct 01; 283(14):763. Castellino RA, Zatz LM, DeNardo GL. PMID: 5311528.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    291. Diagnosis of pulmonary embolism. N Engl J Med. 1970 Aug 27; 283(9):492. DeNardo GL. PMID: 5434126.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    292. The ventilatory lung scan in the diagnosis of pulmonary embolism. N Engl J Med. 1970 Jun 11; 282(24):1334-6. DeNardo GL, Goodwin DA, Ravasini R, Dietrich PA. PMID: 5444646.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    293. Cerebrospinal fluid scanning and ventricular shunts. Radiology. 1970 Feb; 94(2):435-8. Matin P, Goodwin DA, DeNardo GL. PMID: 5412820.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    294. Studies of nutrient blood flow of the dog liver as measured by 133xenon. Surg Forum. 1970; 21:376-8. Duwe SA, DeNardo GL, Helikson MA, Watanabe KS, Crowley LG. PMID: 4936992.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    295. Therapeutic response of intracranial Hodgkin's disease documented by brain scanning. Cancer. 1969 Nov; 24(5):981-4. Thompson RW, DeNardo GL. PMID: 5353949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    296. Radioisotope ventriculography in the Arnold-Chiari malformation. Radiology. 1969 Oct; 93(4):817-21. Castellino RA, Zatz LM, DeNardo GL. PMID: 5307295.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    297. Origin and evolution of radioactive pulmonary emboli in man. Radiology. 1968 Dec; 91(6):1175-80. Duffy GJ, DeNardo GL, Abington RB. PMID: 5699619.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    298. Scintiscanning in malignant lymphomatous involvement of bone. Arch Intern Med. 1968 May; 121(5):433-7. Weber WG, DeNardo GL, Bergin JJ. PMID: 4868925.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    299. Sodium flux in myotonic muscular dystrophy. Am J Physiol. 1968 Feb; 214(2):330-6. Hofmann WW, DeNardo GL. PMID: 5635877.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    300. Comparison of the pulmonary distribution of xenon-133 solution and iodine-131 macroaggregated albumin. J Nucl Med. 1967 May; 8(5):344. DeNardo GL, Brody JS, Leach PJ, Bowes DJ, Glazier JB. PMID: 6032636.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Animal studies with Se75-selenomethionine. J Nucl Med. 1967 May; 8(5):350. DeNardo GL, Crowley L, Pardoe R, Weintraub R. PMID: 6032645.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    302. Dynamic studies with radioisotopes. J Nucl Med. 1967 May; 8(5):373. DeNardo GL, Gorton RJ. PMID: 6032680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    303. Radioisotope skeletal survey. JAMA. 1967 Apr 10; 200(2):111-3. DeNardo GL, Horner RW, Leach PJ, Bowes DJ. PMID: 6071376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    304. Lung scans with I-131 labelled macroaggregated human serum albumin (maa). Am J Roentgenol Radium Ther Nucl Med. 1966 Oct; 98(2):416-26. Sutherland JD, DeNardo GL, Brown DW. PMID: 5925112.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    305. Pulmonary function studied with the xenon-133 scanning technique. Normal values and a postural study. Am Rev Respir Dis. 1966 Aug; 94(2):188-94. Glazier JB, DeNardo GL. PMID: 5915575.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    306. The 85-Sr scintiscan in bone disease. Ann Intern Med. 1966 Jul; 65(1):44-53. DeNardo GL. PMID: 5936666.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    307. Detection of bone lesions with the strontium-85 scintiscan. J Nucl Med. 1966 Mar; 7(3):219-36. DeNardo GL, Volpe JA. PMID: 5952358.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    308. Thyroid function and enovid. Obstet Gynecol. 1966 Feb; 27(2):232-7. Williams DW, Denardo GL, Zelenik JS. PMID: 4160082.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    309. Acute intermittent porphyria associated with hyperthyroidism. J Clin Endocrinol Metab. 1965 Sep; 25(9):1151-5. Mann JG, DeNardo GL. PMID: 5830941.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    310. THE PREOPERATIVE DIAGNOSIS OF SPLEEN CYSTS BY SCINTISCANNING. REPORT OF A CASE. Am J Roentgenol Radium Ther Nucl Med. 1965 Aug; 94:839-43. VOLPE JA, DENARDO GL. PMID: 14320787.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    311. Hereditary spherocytosis and infectious mononucleosis, with acquired hemolytic anemia. Report of a case and review of the literature. Am J Clin Pathol. 1963 Mar; 39:284-8. DENARDO GL, RAY JP. PMID: 14026948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    312. Coccidioidomycosis complicating Hodgkin's disease, with a note on furaltadone-induced neuropathy. Arch Intern Med. 1962 Oct; 110:476-80. DENARDO GL, DANIELL HW, CHILD PL, BUCHANAN DP. PMID: 13885380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Gerald's Networks
    Concepts (783)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California